Talk:Tapentadol
Add topic
| This is the talk page for discussing improvements to the Tapentadol article. This is not a forum for general discussion of the subject of the article. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
| Archives: 1Auto-archiving period: 3.5 years |
| This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
| |||||||||||||||||||||
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tapentadol.
|
Efficacy
[edit]quote <The time to the first dose of rescue medication required was reduced> this would be unusual in an analgesic, as it would mean, the patients who got the real drug suffered more!
Statement about concurrent use with other drugs needs to be rewritten
[edit]The statement in quotes below should be reworked to be something like: Concurrent use of tapendatol with serotonergic drugs can heighten the risk of excessive serotonin accumulation while concurrent use with CNS depressants — alcohol, benzodiazepines, other opioids — can heighten the risk of profound sedation, dangerously slowed breathing, and death.
Here is the way it's currently stated:
"Concurrent use of tapentadol with serotonergic drugs or central nervous system depressants – including alcohol, cannabis, benzodiazepines, and other opioids – can heighten the risks of excessive serotonin accumulation, profound sedation, dangerously slowed breathing and death."
The quote above is how it's currently published and it's unclear about the risks, making it seem as though the concurrent use of benzodiazepines, other opioids, or alcohol with tapendatol can cause excessive serotonergic accumulation, when in reality they can cause added sedation, slowed breathing, and death. The current way it's written conflates the risks as though concurrent use of any drug, even cannabis, can cause excessive serotonin accumulation or slowed breathing when actually it's serotonergic drugs that cause the former and CNS depressants which cause the latter. Cannabis could probably be left out of the statement altogether. I'm not an M.D. so I don't want to change the statement but I think it ought to be rewritten. 420abc (talk) 23:31, 9 July 2026 (UTC)
- I've applied your wording. The source mentions co-current use of tapentadol and cannabis but does not appear (at least as part of my quick skim) to mention that risks this poses. Traumnovelle (talk) 02:47, 10 July 2026 (UTC)
- Thank you very much, I really appreciate your time and input and for reading and responding to my post. I don't believe concurrent use of any opioids/opiates with cannabis poses any serious risk as they affect different neurotransmitters and cannabis isn't a true central nervous system depressant. I've yet to hear of any legitimate risk from the combination. 420abc (talk) 17:52, 11 July 2026 (UTC)
should tapentadol be called "highly addictive" & "commonly abused"?
[edit]In the beginning of the article it says tapentadol is "highly addictive" and "commonly abused." Later in the article it says tapentadol's strength is somewhere between tramadol (one of the weakest narcotics) and morphine. To me that makes it closer to a moderately addictive drug rather than highly. According to ClinCalc's top 200 & 300 prescribed drugs in the US for 2014-2023, tapentadol doesn't make the list any year while uncommon prescription drugs like pure, non-combination versions of codeine and hydrocodone make the list yearly and in 2023 had just over 200,000 & 79,000 prescriptions respectively. This means tapentadol likely had fewer than 70,000 prescriptions in 2023. It's incorrect, at least in the US, to label tapentadol a "commonly abused" drug unless there's data proving the majority of prescriptions get diverted to the black market but even then it's a stretch given the extremely extremely low prescription rates.
Regarding tapentadol being "highly addictive" I think that phrasing makes it seem on par with the most addictive/dependence causing opioids like heroin, oxycodone, hydromorphone, oxymorphone, and fentanyl. There should be some distinction between the different types of opioids. Codeine and tramadol aren't as potent or addictive as oxycodone and fentanyl. Nor are they used for the same purposes. It would be beneficial to have a clear distinction between the different classes of opioids based on potency and indicated uses.
In some provinces in India tapentadol is OTC. Because of that it's more widely used/abused there, but basically everywhere else it's extremely regulated and controlled with far fewer users & prescriptions than nearly every other available opiate/opioid.
I think it's fair to say tapentadol is "moderately to highly" addictive and dependence-causing, but not a commonly abused drug. I think including the word "moderately" provides a more accurate idea of the nature of the drug's addictiveness.
I'm not a medical doctor but I think my reasoning makes sense. 420abc (talk) 19:58, 11 July 2026 (UTC)